key: cord-0993200-2422q93w
authors: Owolabi, Olumuyiwa A.; Jallow, Alpha O.; Jallow, Momodou; Sowe, Gambia; Jallow, Rohey; Genekah, Monica D.; Donkor, Simon; Wurrie, Alieu; Kampmann, Beate; Sutherland, Jayne; Togun, Toyin
title: Delay in diagnosis of pulmonary tuberculosis in The Gambia, West Africa: a cross-sectional study
date: 2020-09-16
journal: Int J Infect Dis
DOI: 10.1016/j.ijid.2020.09.029
sha: 0459aaa7890360aeabad92d7dc91e06148b5c216
doc_id: 993200
cord_uid: 2422q93w

OBJECTIVES: To investigate the pattern of tuberculosis (TB) care initiation and risk factors for TB diagnostic delay in The Gambia. METHODS: In this cross-sectional study, adult patients diagnosed with pulmonary TB (pTB) in public facilities in the Greater Banjul Area of The Gambia were consecutively recruited from October 2016 to March 2017. Diagnostic delay was defined as >21 days from onset of at least one symptom suggestive of pTB to diagnosis. Logistic regression analyses were used to investigate risk factors for diagnostic delay. RESULTS: Overall, 216 pTB patients were included in the study; the median (IQR) age was 30 (23-39) years and 167 (77%) were males. 110/216 (50.9%) initiated care-seeking in the formal and informal private sector, and 181/216 (83.8%) had TB diagnostic delay. The median (IQR) duration from onset of symptoms to TB diagnosis was 34 (28-56) days. Age groups 18-29 years (aOR 3.2; 95% CI 1.2 - 8.8 [p = 0.02]) and 30-49 years (aOR 5.1; 95% CI 1.6 – 16.2 [p = 0.006]), and being employed (aOR 4.2; 95% CI 1.7- 10.5 [p = 0.002]) were independent risk factors for TB diagnostic delay. CONCLUSION: There is considerable TB diagnostic delay in The Gambia and this is likely to be worsened by the COVID-19 pandemic.

Globally, tuberculosis (TB) is the leading cause of death from a single infectious disease (Boggiano et al., 2017 ). An estimated 10 million new cases of TB and 1.5 million TB deaths J o u r n a l P r e -p r o o f were reported in 2018 (World Health Organization (WHO), 2019). The current public health strategy for the control of TB in high burden settings is geared towards early detection of infectious TB patients, mostly through passive, as opposed to active, case detection, followed by prompt initiation of treatment (Sreeramareddy et al., 2014) . In low-and middle-income countries (LMICs) with high TB burden, the focus has been on passive case detection of TB in national health systems (Fuge et al., 2018) . Passive TB case detection is influenced by several factors, including the subject's perception of the severity of the illness, awareness of the likely cause of their symptoms, stigma, access to health facilities well-equipped to screen for TB, and on the level of TB symptoms recognition that will trigger investigation by the care provider at the time of first presentation by the patients (Shewade et al., 2019) . However, this approach has been less effective in LMICs where there is poor access to health care facilities with appropriate diagnostic tools, poor TB symptom awareness, and inadequate community and social mobilisation to support effective passive case finding (Shewade et al., 2019) This has resulted in considerable TB diagnostic delay that negatively impact the whole cascade of care, fuelling the increasing number of missed cases of TB each year, presently estimated globally at 3 million (World Health Organization (WHO), 2019).

There is growing interest in quality of TB care in TB endemic settings . The provision of high quality of care for TB patients, with emphasis on rapid and accurate diagnosis and on patient-centred outcomes, is one of the cardinal objectives of the End TB Strategy of the World Health Organization (WHO) (Uplekar et al., 2015) . Surya et al reported that 75% of TB patients in Indonesia initiated TB care in the private sector lacking appropriate diagnostic facilities for TB (Surya et al., 2017) . A combined patients pathway analysis (PPA) from 13 countries, which included six African countries with the highest TB burden on the continent, reported that about 60% of all TB patients initiated care from private sector, and less than 50% of estimated TB patients had documented treatment success (Chin and Hanson, 2017) .

A cascade of TB patient care analysis in South Africa reported that only 53% of TB patients in South Africa were diagnosed and successfully treated (Naidoo et al., 2017) . Taken together, the current public health approach for the control of TB in high-burden countries is characterised by TB diagnostic delay as well as delay in initiation of effective treatment with poor rates of treatment success, all of which are considered surrogates for quality of TB care (Cazabon et al., 2017) .

Diagnosis of TB and initiation of treatment in The Gambia is based primarily on passive case detection (Lienhardt et al., 2001) . Therefore, we aimed to investigate the pattern of TB care initiation and the risk factors associated with TB diagnostic delay, among newly diagnosed adult pulmonary TB patients in The Gambia.

In The Gambia, the incidence rate of TBis 174 cases/100,000 population (World Health Our study population were consecutive adult subjects (age ≥ 18 years) who were newly diagnosed with sputum-smear positive pulmonary TB (pTB) disease at either of three health centres (Brikama, Fajikunda and Serrekunda Health Centres) or the MRC Gambia TB clinic in the GBA. Sputum smear microscopy is still the first and only tool for routine diagnosis of TB in most public health facilities providing comprehensive primary health care, including TB diagnosis, in The Gambia. GeneXpert test is additionally available at the MRC Gambia at entry point for potential research participants in the TBCC cohort. The TB clinics in these four public health facilities collectively account for approximately 80% of all TB diagnosis in the GBA annually (Gambian National Leprosy and Tuberculosis Control Programme (NLTP), 2012; Lienhardt et al., 2001) . Study participants were interviewed by trained nurse/field workers within one week of their TB diagnosis. A structured questionnaire was used to collect data on the sociodemographic J o u r n a l P r e -p r o o f characteristics, symptoms at presentation, and health care seeking behaviours of the study participants (see supplementary material). All study participants were initiated on standard antituberculosis treatment by direct observation according to the Gambian National TB Guidelines (Gambian National Leprosy and Tuberculosis Control Programme (NLTP), 2012). Health care providers are persons consulted by patients for their ailments with the aim of obtaining advice or prescription, as previously described (Lienhardt et al., 2001) .

TB diagnostic delay was defined as more than 21 days from onset of at least one symptom of TB before diagnosis, according to the WHO (World Health Organization (WHO), 1997).

Participants' characteristics were summarized using numbers (percentages) for categorical variables and median (Interquartile Range [IQR]) for quantitative variables. We investigated factors associated with TB diagnostic delay by univariate and multivariable logistic regression analysis. Age, sex and variables with p-value <0.20 in the univariate analysis were included in the multivariable analysis. All analyses were performed using STATA version 16 (StataCorp, College Station, Texas, United States). P-values <0.05 were considered statistically significant.

All the 216 subjects diagnosed with sputum smear positive pTB in the four public facilities over the study period agreed to participate in the study. The median (IQR) age of the study participants was 30 (23 -39) years, and all of them were HIV negative. One hundred and sixtyseven (77.3%) were males and 106 (49.1%) unemployed ( 

Of the 216 patients with pTB, 110 (50.9%) initiated TB care-seeking in the formal and informal private sector, comprising (traditional healers (n=9), dispensaries (n=8) pharmacy shops (n=49) and private clinics (n=44). (Figure 1) . The median (IQR) number of visits to health facilities before TB diagnosis were 3 (2 -4) visits. The median (IQR) duration from onset of at least one symptom suggestive of TB to diagnosis was 34 (28, 56) days, and 181 patients (83.8%) had more than 21 days from the onset of TB symptoms to diagnosis. One hundred and fifty-nine (73.6%) J o u r n a l P r e -p r o o f out of all the newly diagnosed participants with pTB in this analysis reported that they had sought care at both private and public health care facilities before diagnosis.

In the univariate analysis, we found that pTB patients aged 30-49 years (crude OR 5.2; 95% CI 1.8-15.2[p=0.003]) and those employed (crude OR 3.6; 95% CI 1.6-8.2[p=0.001]) had significantly higher odds of TB diagnostic delay relative to patients aged 50 years and those with no employment, respectively. Sex, marital status, tribe, having formal education and the care provider pattern were not associated with TB diagnosis delay ( 

Our study reports on the care-seeking pattern and diagnostic delay among newly diagnosed adult patients with pTB in The Gambia, West Africa, prior to the COVID-19 pandemic. We found that half of all newly diagnosed adult pTB patients in the GBA initiated care in the formal or informal private sector, and approximately 84% had delays to their TB diagnosis as defined by the WHO i.e. more than 21 days from onset of symptoms suggestive of TB to diagnosis (World Health Organization (WHO), 1997). Also, the odds of TB diagnostic delay were, at least, three times higher in patients younger than 50 years of age and those who were employed compared to older-aged patients or those who were unemployed. In The Gambia, sputum smear microscopy is still the first and only diagnostic test for TB in routine public health system. The diagnosis of TB and provision of anti-TB drugs are only available in public health facilities (Gambian National Leprosy and Tuberculosis Control Programme (NLTP), 2012). Although 49% of our study participants initiated care seeking in public facilities, the finding that more than 80% of all participants in this study had TB diagnostic delay, and our finding of no significant difference in the odds of TB diagnostic delay between participants who sought care in public facilities only and those who had sought care in both public and private facilities before TB diagnosis, highly suggest that there could be delays in testing and missed opportunities for early J o u r n a l P r e -p r o o f recognised limitations of sputum smear microscopy as the only TB diagnostic test available in routine public health system in The Gambia could have contributed to this delay. Thus, the findings further highlight the need for sputum smear microscopy replacement with WHOendorsed rapid diagnostic (WRD) tests (World Health Organization (WHO), 2020), and the potential for scaling up of molecular diagnostic tests for TB in The Gambia.

Furthermore, we found that TB patients made an average of three visits to health care providers while almost three-quarters sought care at both private and public health care facilities before diagnosis of TB was made. Our finding that TB patients made an average of three visits to health care facilities before diagnosis is similar to that of a systematic review of 23 studies from different parts of India in which patients made an average of three visits to health care providers before diagnosis (Sreeramareddy et al., 2014) .This finding however seems to be an improvement over the finding in a previous study conducted in The Gambia that TB patients visited an average of four health care providers, and possibly even greater number of actual visits, before TB diagnosis (Lienhardt et al., 2001) , , However, another study from Italy,, a high-income country, reported that TB patients had an average of two visits before diagnosis (Peri et al., 2018) .

Approximately 51% of the adult TB patients in our study initiated care in the formal and informal private sector where studies in LMICs have shown that such providers often lack knowledge of TB symptoms, and TB diagnostic facilities are frequently unavailable (Cazabon et al., 2020; Daniels et al., 2019; Das et al., 2015) . This finding is comparable to the report of a combined patients pathway analysis (PPA) from 13 high TB burden countries in Africa and south-East Asia, where about 60% of all TB patients initiated care in the private sector (Chin and Hanson, 2017) .

The median duration from onset of TB symptoms to diagnosis in our study was 34 days, which is comparable to the 30 days reported from a study in Ethiopia (Fuge et al., 2018) . This duration in our study is however shorter than durations in excess of 45 days reported from studies in Angola, Tunisia and Brazil (Ben Amar et al., 2016; Machado et al., 2011; Segagni Lusignani et al., 2013) . In contrast to our study, these studies included patients with smear-negative TB, extra-J o u r n a l P r e -p r o o f pulmonary TB and culture-positive TB disease, which could explain the longer duration from onset of TB symptoms to diagnosis.

Our study showed that age <50 years and being employed were strong and independent risk factors for TB diagnosis delay. These probably reflect the socio-economic realities of subjects battling ill-health in the low-income setting of The Gambia, where the need for economic survival trumps health care seeking. Older aged patients are probably retired and/or fully dependent on relatives for care. However, in contrast to our report, a systematic review of 45 studies from Asia reported that older age is strongly associated with delays in TB diagnosis (Cai et al., 2015) . We did not find any association between gender, marital status, having formal education and TB diagnostic delay. Other studies had reported that female gender was associated with TB diagnostic delay (Ben Amar et al., 2016; Cai et al., 2015; Ndeikoundam Ngangro et al., 2012; Peri et al., 2018; Saldana et al., 2013) .

It is very likely that the care-seeking behaviour and delays in TB diagnosis in The Gambia will be further impacted by the advent of the COVID-19 pandemic. Our recently published review article on the impact of the COVID-19 pandemic on TB patients and control programmes highlighted the likely grave consequences for existing and undiagnosed TB patients particularly in LMICs where TB is endemic and health services poorly equipped (Togun et al., 2020) . This assertion is supported by another study that modelled the impact of the COVID-19 response on TB in high-burden countries that suggests that the two months of lockdown and of recovery will add an excess of 1.8 million TB cases over the next five years (Stop TB Partnership, 2020) .

Our study has limitations: the small sample size might not have allowed sufficient statistical power to detect meaningful differences across strata. Also, the study was conducted in the largely urban Greater Banjul area of the Gambia, and the findings might not be generalisable to the rural areas of The Gambia. However, the overwhelming majority of TB cases in The Gambia are notified in the densely populated GBA.

This exploratory study has highlighted the considerable delay in diagnosis of TB in The Gambia, and provides a benchmark against which we can measure efforts to better understand and improve the overall quality of TB care in the country during the COVID-19 pandemic. There is J o u r n a l P r e -p r o o f an urgent need for larger prospective studies to better understand TB patients pathways to care, especially the roles of age and socio-economic factors in care-seeking behaviour of presumed TB patients, as well as the best modalities for engaging the private sector in the national TB control program. A standard cascade of TB care analysis is also needed to accurately estimate the proportions of total TB patients evaluated, diagnosed, initiated on treatment and successfully treated, and the losses at each step of the cascade.

OAO and TT conceptualised and designed the study. OAO, MDG and AW coordinated recruitment of study subjects. AOJ, MJ, GS and RJ recruited and interviewed study participants. The sponsors of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication. the diagnosis of tuberculosis and rifampicin resistance. WHO, Geneva, Switzerland. Available from: https://apps.who.int/iris/rest/bitstreams/1264904/retrieve [cited 1 September 2020]2020.

J o u r n a l P r e -p r o o f 

Pulmonary tuberculosis: Diagnostic delay in Tunisia

The Impact of Mycobacterium tuberculosis Immune Evasion on Protective Immunity: Implications for TB Vaccine Design" -Meeting report

Factors associated with patient and provider delays for tuberculosis diagnosis and treatment in Asia: a systematic review and meta-analysis

Quality of tuberculosis care in high burden countries: the urgent need to address gaps in the care cascade

User experience and patient satisfaction with tuberculosis care in low-and middle-income countries: A systematic review

Finding the Missing Tuberculosis Patients

Lessons on the quality of tuberculosis diagnosis from standardized patients in China

Use of standardised patients to assess quality of tuberculosis care: a pilot, cross-sectional study

Isoniazid preventive treatment among child contacts of adults with smear-positive tuberculosis in The Gambia

Patient delay in seeking tuberculosis diagnosis and associated factors in Hadiya Zone, Southern Ethiopia

National Guidelines for The Management of Tuberculosis. Banjul, The Gambia: Department of State for Health, The Gambia

Tuberculosis case-contact research in endemic tropical settings: design, conduct, and relevance to other infectious diseases

Factors affecting time delay to treatment in a tuberculosis control programme in a sub-Saharan African country: the experience of The Gambia

Factors associated with delayed diagnosis of pulmonary tuberculosis in the state of Rio de Janeiro, Brazil

The South African Tuberculosis Care Cascade: Estimated Losses and Methodological Challenges

Revue d'epidemiologie et de sante

Determinants of patient and health care services delays for tuberculosis diagnosis in Italy: a cross-sectional observational study

Factors affecting delay in initiation of treatment of tuberculosis in the Thames Valley

Quality of tuberculosis care in India: a systematic review

Factors associated with patient and health care system delay in diagnosis for tuberculosis in the province of Luanda

Patient characteristics, health seeking and delays among new sputum smear positive TB patients identified through active case finding when compared to passive case finding in India

Delays in diagnosis and treatment of pulmonary tuberculosis in India: a systematic review

Tuberculosis Situation in The Gambia

The potential impact of the COVID-19 response on tuberculosis in highburden countries: a modelling analysis

Quality Tuberculosis Care in Indonesia: Using Patient Pathway Analysis to Optimize Public-Private Collaboration

Anticipating the impact of the COVID-19 pandemic on TB patients and TB control programmes

WHO's new end TB strategy

Treatment of tuberculosis: guidelines for national programmes. Geneva: World Health Organization

World Health Organization (WHO)

The authors are grateful to the MRCG at LSHTM field and clinic teams (Nurses/ field assistants, Nurse coordinators, field workers and supervisors, etc.) who facilitated the recruitment, screening and follow-up of the study participants; the National Tuberculosis and Leprosy programme managers; and the study participants and their families who participated in the research project.J o u r n a l P r e -p r o o f

The authors have declared no conflict of interest.

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. J o u r n a l P r e -p r o o f